News
Videos
Conferences
Events
Resources
Subscribe

|Videos|January 20, 2016

Locating Support Resources for Patients

Episodes in this series

EP. 1 Treatment Options and Challenges for Patients With Pancreatic Cancer

EP. 1 Treatment Options and Challenges for Patients With Pancreatic Cancer

EP. 2 A Promising Future for Pancreatic Cancer

EP. 2 A Promising Future for Pancreatic Cancer

EP. 3 Pancreatic Cancer: David's Story to Remission

EP. 3 Pancreatic Cancer: David's Story to Remission

EP. 4 Pancreatic Cancer: Donald's Story

EP. 4 Pancreatic Cancer: Donald's Story

EP. 5 Locating Support Resources for Patients

EP. 5 Locating Support Resources for Patients

EP. 6 Treatment Considerations for Patients Researching Their Options

EP. 6 Treatment Considerations for Patients Researching Their Options

EP. 7 Moving Forward With Pancreatic Cancer

EP. 7 Moving Forward With Pancreatic Cancer

EP. 8 Receiving a Second Opinion

EP. 8 Receiving a Second Opinion

EP. 9 Maintenance Therapy: What to Expect

EP. 9 Maintenance Therapy: What to Expect

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Angela Patterson

Finding Cancer Support in Different Places For Different Diagnoses

ByAngela Patterson

December 23rd 2025

Image of breast.

Clinical Trials: Tomorrow's Treatment Today in Metastatic Breast Cancer

December 23rd 2025

Trodelvy led to fewer side effects that required dose reductions or stopping treatment vs chemo among previously untreated triple-negative breast cancer: © stock.adobe.com.

Trodelvy Shows Fewer Severe Side Effects vs Chemo in Untreated TNBC

December 23rd 2025

Image of woman.

Top 5 Breast Cancer Updates From the 2025 San Antonio Breast Cancer Symposium

December 23rd 2025

"FDA"

FDA Grants Breakthrough Status to Enhertu for Some HER2+ Early Breast Cancers

December 23rd 2025

Trending on CURE

Top 10 Cancer Care Updates of 2025: What Patients Should Know

What No One Tells You About Life After Breast Cancer: Fighting for Care

Top 5 Breast Cancer Updates From the 2025 San Antonio Breast Cancer Symposium

Enhertu Improves Survival Over Kadcyla In Early Stage HER2+ Breast Cancer

FDA Grants Breakthrough Status to Enhertu for Some HER2+ Early Breast Cancers